Regeneron Pharmaceuticals Inc (REGN) EVP Research and Development Neil Stahl Sold $4.7 million of Shares

Author's Avatar
Feb 28, 2020
Article's Main Image

EVP Research and Development of Regeneron Pharmaceuticals Inc (30-Year Financial, Insider Trades) Neil Stahl (insider trades) sold 10,349 shares of REGN on 02/27/2020 at an average price of $452.26 a share. The total sale was $4.7 million.

Regeneron Pharmaceuticals Inc is an integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron Pharmaceuticals Inc has a market cap of $48.91 billion; its shares were traded at around $444.57 with a P/E ratio of 24.07 and P/S ratio of 6.48. Regeneron Pharmaceuticals Inc had annual average EBITDA growth of 26.80% over the past five years. GuruFocus has detected 1 severe warning sign with Regeneron Pharmaceuticals Inc. .

CFO Recent Trades:

  • EVP Finance CFO Robert E Landry sold 414 shares of REGN stock on 02/26/2020 at the average price of $452.49. The price of the stock has decreased by 1.75% since.
  • EVP Finance CFO Robert E Landry sold 107 shares of REGN stock on 02/13/2020 at the average price of $400.05. The price of the stock has increased by 11.13% since.

Directors and Officers Recent Trades:

  • EVP Research and Development Neil Stahl sold 10,349 shares of REGN stock on 02/27/2020 at the average price of $452.26. The price of the stock has decreased by 1.7% since.
  • Director George L Sing sold 4,900 shares of REGN stock on 02/26/2020 at the average price of $456.49. The price of the stock has decreased by 2.61% since.
  • EVP & General Mgr Industrial O Plew Daniel P Van sold 15,642 shares of REGN stock on 02/26/2020 at the average price of $457.23. The price of the stock has decreased by 2.77% since.
  • President and Chief Scientific George Yancopoulos sold 118,123 shares of REGN stock on 02/24/2020 at the average price of $420.17. The price of the stock has increased by 5.81% since.
  • Director Michael S Brown sold 2,000 shares of REGN stock on 02/24/2020 at the average price of $419. The price of the stock has increased by 6.1% since.

For the complete insider trading history of REGN, click here

.